67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05478083 (ClinicalTrials.gov)	June 1, 2022	9/5/2022	A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease	A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease	Polycystic Liver Disease;Autosomal Dominant Polycystic Kidney	Drug: Leuprorelin	University Medical Center Groningen	Radboud University Medical Center	Recruiting	18 Years	45 Years	Female	36	Phase 2	Netherlands
2	EUCTR2020-005949-16-NL (EUCTR)	25/10/2021	21/10/2021	A study into the efficacy and toleratability of leuprorelin by patients suffering from severe polycystic liver disease	A GnRH Agonist IN pre-menopausal women STudy to treat severe Polycystic Liver Disease - AGAINST-PLD	Severe polycystic liver disease in female patients MedDRA version: 20.1;Level: PT;Classification code 10048834;Term: Polycystic liver disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 20.0;Level: LLT;Classification code 10036045;Term: Polycystic kidney;Classification code 10036046;Term: Polycystic kidney, autosomal dominant;System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 23.0;Classification code 10083939;Term: Autosomal dominant polycystic liver disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]	Trade Name: Lucrin Product Name: Lucrin	University Medical Center Groningen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: no	36	Phase 2	Netherlands